Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Inc (GYRE) Financials

GYRE Gyre Therapeutics Inc

10.02

-0.97 (-8.83%)

12 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-31.493	-65.75	-36.556	-49.382	-58.16	-116.848	-19.599	-128.198
Return on Equity (%)	-71.353	-108.921	-39.882	-58.612	-77.893	-150.11	-84.969	2401.37
Return on Invested Capital (%)	-86.433	-93.673	-45.082	-61.102	-81.331	-154.723	-254.067	-254.2
Operating Margin (%)	-4246.867	-2117.976	-500916.667	N/A	-268.479	-1198.324	-994.207	-67.84
Net Profit Margin (%)	-4246.867	-2506.09	-500916.667	N/A	-268.479	-1198.324	-1038.035	-81.915
Book Value Per Share	20.039	5.061	10.033	5.675	3.442	1.308	0.308	2.061
Earnings Per Share	-21.128	-4.195	-2.514	-4.583	-2.545	-2.8	-0.218	-2.447
Cash Per Share	12.798	2.38	2.611	1.276	1.374	1.412	0.574	0.882
Working Capital Per Share	19.397	4.994	9.97	5.578	3.245	1.188	0.301	0.979
Operating Profit Per Share	0.498	0.167	0.001	N/A	0.533	-0.001	N/A	2.893
EBIT Per Share	-21.128	-3.546	-2.514	-4.583	-2.545	-2.8	-0.209	-2.027
EBITDA Per Share	-21.128	-3.546	-2.514	-4.583	-2.545	-2.8	-0.209	-2.027
Free Cash Flow Per Share	-21.03	-4.22	-2.495	-4.589	-2.539	-2.809	1.168	-2.249

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	802k	6.08M	11.96M	12.04M	22.1M	31.41M	37.76M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	37.76M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	45.933	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	27.72	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.03B
Price to Earnings Ratio	-10.09
Price to Sales Ratio	8.27
Price to Cash Ratio	27.99
Price to Book Ratio	11.95
Dividend Yield	-

Share Statistics

Shares Outstanding	93.52M
Average Volume (1 week)	194.99k
Average Volume (1 Month)	119.34k
52 Week Change	-52.29%
52 Week High	30.40
52 Week Low	8.26

More Ratios Coming Soon!

Gyre Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions